Ummino is a privately held biotechnology company headquartered in Durham, North Carolina, pioneering clinically grounded microbiome solutions and vital prebiotics for the metabolic health market.
Subscribe to see Ummino’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
Ummino is a biotechnology company headquartered in Durham, United States. Xcout tracks 8 named people at Ummino, including Alex Riley (Chief Financial Officer).
As of 16 November 2026. Source: Xcout Intel.
2 more named people on record for Ummino, with roles, board committees and tenure — see the full roster →
A few of Ummino's closest competitors — see the full list of competitors and alternatives →
Pendulum Therapeutics is a biotechnology company headquartered in San Francisco, California. Founded by scientific experts, it develops next-generation microbiome products and probiotic solutions to improve metabolic health.
Synbiotic Health, Inc. is a U.S. biotechnology company that develops and commercializes synbiotic ingredients combining probiotics and prebiotics, including strain-based products supported by scientific research. It serves food, beverage, dietary-supplement, and other consumer-health product manufacturers.
ClostraBio, Inc. is a biotechnology research company pioneering microbiome-based solutions to promote gastrointestinal health. The company is headquartered in Chicago, Illinois.
One.bio is a biotechnology spinout from UC Davis that develops naturally derived oligosaccharides and water-soluble fibers from agricultural waste for food, agriculture, and biopharmaceutical applications. The company utilizes proprietary technology to process polysaccharides into invisible, tasteless fibers designed to support metabolic and immune health.
OptiBiotix Health Plc, a life sciences enterprise headquartered in York, United Kingdom, specializes in the discovery and advancement of microbiome-modulating technologies. The company formulates distinct microbial strains, innovative compounds, and tailored blends intended for integration into food products, nutritional supplements, and active ingredients. Their groundbreaking work aims to positively influence human physiology and yield substantial health benefits. Among its diverse product portfolio are Slimbiome, a natural ingredient for healthy and satiety-driven weight management, and SlimBiome Medical, a supplemental aid for weight control. Other offerings include CholBiome, a dietary supplement for maintaining healthy cholesterol; Lactobacillus plantarum LPLDL, a probiotic supporting cardiovascular health and overall well-being; LPGOS, a galactooligosaccharide utilized in food applications to mitigate cardiovascular risk factors and enhance general health; WellBiome, a functional fiber and mineral blend designed to bolster gut microbiome diversity and promote wellness; and Sweetbiotix, a sweetener for use in various foods and beverages. Ultimately, OptiBiotix's innovations are designed to prevent and manage prevalent chronic lifestyle diseases, including obesity, high cholesterol, and diabetes. The company was founded in 2012.
Federation Bio is a U.S. biotechnology company developing live biotherapeutic products based on defined microbial communities to treat diseases. Its work has focused on microbiome-based therapies for metabolic and other serious disorders, serving patients with conditions that may benefit from engineered microbial consortia.
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Something wrong or missing about Ummino? Suggest a correction · Work at Ummino? Claim this profile
Post the link and the card appears automatically — each network fetches the image itself.